22nd ANNUAL
MARKET ACCESS
SUMMIT

The largest and longest-running market access conference in Canada

Toronto, ON

Wednesday, October 11 &
Thursday, October 12, 2023

CONQUER YOUR MARKET ACCESS CHALLENGES & THRIVE IN A TRANSFORMED PHARMA LANDSCAPE

The 22^nd Annual Market Access Summit returns to Toronto in 2023 with industry experts to help you navigate a new pharma market environment. This year is proving to be a pivotal year in Canada’s pharma market. With Covid behind us, there are several new developments taking place that will have major impacts on market access and reimbursement success. Secure your spot today to:

Understand how Health Canada’s new National Strategy for Rare Diseases is unfolding.
Gain valuable insight on how prepared Canada is for the new wave of treatments on the horizon.
Discover how the increased substitution of biosimilars and the new generic agreement will impact the pharma marketplace.
Realize the transformative impact that greater collaboration on gathering and sharing real-world evidence (RWE) is having on market access.
Determine how Patient Support Programs (PSPs) need to evolve to ensure patients have access to the new treatments they require.

Get your ticket to join Canada’s top pharma industry players from both the public and private sectors, including Health Canada, Government of Manitoba, BC Ministry of Health, INESSS, CADTH, CGPA, IMC, BioCanRx, AstraZeneca, Crohn’s and Colitis Canada, Canada Life, Green Shield, Bristol-Myers Squibb, Mitsubishi Tanabe Pharma, TEVA, University of Toronto, McMaster University, and many more!

This year’s edition is an in-person event featuring interactive sessions, curated breakout learning, and face-to-face networking opportunities. The conference will also be streamed virtually for increased reach and higher engagement.

SOURCE ACTIONABLE MARKET ACCESS STRATEGIES

Align your market access strategies with the latest developments at CADTH and INESSS.
Discover the way forward for treatments for rare diseases under Health Canada’s new National Strategy for Drugs for Rare Diseases.
Understand the increasing role that generics and biosimilars are playing as the lynchpin of the sustainability of the healthcare system.
Gain valuable insight on the current state of pharmacare that will significantly impact the Canadian pharma market.
Develop best practices in negotiating with private payers.

VIEW AGENDA

HARNESS THE POWER OF AN IN-PERSON & VIRTUAL EVENT

This hybrid experience is specially designed to help attendees capture the most value possible!

Expand your network and enhance peer-to-peer learning with a larger audience and a broader reach of attendees.
Cultivate lasting connections through one week of pre-event virtual networking on the summit platform.
Consult industry experts and get your toughest questions answered with the help of an in-person and virtual exhibitor hall.
Connect and build relationships with peers who have similar interests and career objectives using AI matchmaking tools and filters.
Enjoy on-demand speaking sessions and content that can be viewed anytime, anywhere.

SAVE MY SEAT

2023 FEATURED SPEAKERS

André Picard

Author and Journalist, Health Reporter and Columnist

Daniel MacDonald

Director General, Drugs for Rare Diseases

Sylvie Bouchard

Director, Drug Evaluation and Technology Assessment for Reimbursement

Brent Fraser

Vice-President, Pharmaceutical Reviews

Ned Pojskic

Vice President, Pharmacy Benefits Management

Jim Keon

President

Dr. Stéphanie Michaud

President and Chief Executive Officer

Mo Amin

Vice President, Value, Access & Policy

SEE ALL SPEAKERS

DRIVE DEMAND GENERATION WITH INTENT-BASED BUYERS

The Market Access Summit brings together the biggest names in Canada’s healthcare industry and provides them with leading solutions. It enables them to access strategically focused content in an environment conducive to forging lasting business partnerships.

This is your opportunity to cultivate relationships with the industry’s key influencers and buyers at this exclusive event. Build your pipeline with qualified sales leads by taking advantage of one of our limited sponsorship opportunities now.

SEE SPONSORSHIP OPPORTUNITIES

Testimonials

The morning session was impactful as they discussed and presented real and practical information, sharing case studies and thought input.

GC Biotherapeutics Inc.
Conference is a good use of my time.

Sanofi
… Event format was conclusive for networking. Variety of sessions provided good breadth of information.

The Rounds
Very good speakers and interaction with timely and important topics.

Aptus Health
Lots of great info. Diverse topics. Very well organized and run. No backup with registration.

Delta Eight Pharmaceuticals
Valuable insight, thought-provoking sessions.

Brant Community Healthcare System